{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Chu F"],"funding":["CAMS Innovation Fund for Medical Sciences","State Key Laboratory of Advanced Medical Materials and Devices Research Grant","the Natural Science Foundation of Tianjin","National Natural Science Foundation of China","the Postdoctoral Fellowship Program of CPSF","Fundamental Research Funds for the Central Universities of Peking Union Medical College"],"pagination":["1962-1982"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12825367"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["20(2)"],"pubmed_abstract":["Amyloid-β (Aβ) is considered a core pathological feature of Alzheimer's disease (AD), and its clearance efficiency is highly dependent on the function of the Piezo1 channel in microglia. However, the activity of Piezo1 is impaired under the pathological conditions of AD, and existing pharmacological strategies struggle to achieve precise targeted intervention in deep brain regions. To address these concerns, our research proposes a synergistic therapeutic paradigm leveraging transcranial magneto-acoustic stimulation (TMAS) to actuate microglial-Piezo1-targeted magnetic nanobubbles (PT-MNBs) for AD treatment. TMAS noninvasively focuses physical energy into deep brain lesion areas through a magnetoacoustic coupling field and drives PT-MNBs to generate responsive mechanical and electrical sti"],"journal":["ACS nano"],"pubmed_title":["Piezo1-Targeted Magnetoacoustic Nanobubbles Rescue Alzheimer's Pathology by Electromechanical Neuromodulation and Amyloid-β Clearance."],"pmcid":["PMC12825367"],"funding_grant_id":["3332025197","24ZXZSSS00110","2022-12M-2-003","GZC20251897","24JCYBJC00570","823B2028","81927806","32330059","2021-I2M-1-058","52077223","2025M772880"],"pubmed_authors":["Liu X","Ma R","Li Y","Liu Z","Yin T","Chu F","Zhu K","Liu R","Wang X","Wang Y","Zhang S","Zhou X"],"additional_accession":[]},"is_claimable":false,"name":"Piezo1-Targeted Magnetoacoustic Nanobubbles Rescue Alzheimer's Pathology by Electromechanical Neuromodulation and Amyloid-β Clearance.","description":"Amyloid-β (Aβ) is considered a core pathological feature of Alzheimer's disease (AD), and its clearance efficiency is highly dependent on the function of the Piezo1 channel in microglia. However, the activity of Piezo1 is impaired under the pathological conditions of AD, and existing pharmacological strategies struggle to achieve precise targeted intervention in deep brain regions. To address these concerns, our research proposes a synergistic therapeutic paradigm leveraging transcranial magneto-acoustic stimulation (TMAS) to actuate microglial-Piezo1-targeted magnetic nanobubbles (PT-MNBs) for AD treatment. TMAS noninvasively focuses physical energy into deep brain lesion areas through a magnetoacoustic coupling field and drives PT-MNBs to generate responsive mechanical and electrical sti","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Jan","modification":"2026-06-12T05:22:07.845Z","creation":"2026-06-12T03:07:48.558Z"},"accession":"S-EPMC12825367","cross_references":{"pubmed":["41399980"],"doi":["10.1021/acsnano.5c13702"]}}